Ethyl (3R,4R)-1-benzyl-8-(cyclobutanecarbonyl)-3-hydroxy-2-oxo-1,8-diazaspiro[4.5]decane-4-carboxylate
C23H30N2O5 — CID 134786325
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethyl (3R,4R)-1-benzyl-8-(cyclobutanecarbonyl)-3-hydroxy-2-oxo-1,8-diazaspiro[4.5]decane-4-carboxylate
Ethyl (3R,4R)-1-benzyl-8-(cyclobutanecarbonyl)-3-hydroxy-2-oxo-1,8-diazaspiro[4.5]decane-4-carboxylate (PubChem CID 134786325) has the molecular formula C23H30N2O5 and a molecular weight of 414.50 g/mol. Its IUPAC name is ethyl (3R,4R)-1-benzyl-8-(cyclobutanecarbonyl)-3-hydroxy-2-oxo-1,8-diazaspiro[4.5]decane-4-carboxylate.
Molecular Properties
| Compound Name | Ethyl (3R,4R)-1-benzyl-8-(cyclobutanecarbonyl)-3-hydroxy-2-oxo-1,8-diazaspiro[4.5]decane-4-carboxylate |
|---|---|
| PubChem CID | 134786325 |
| Molecular Formula | C23H30N2O5 |
| Molecular Weight | 414.50 g/mol |
| Exact Mass | 414.22 |
| IUPAC Name | ethyl (3R,4R)-1-benzyl-8-(cyclobutanecarbonyl)-3-hydroxy-2-oxo-1,8-diazaspiro[4.5]decane-4-carboxylate |
| SMILES | CCOC(=O)[C@H]1[C@@H](O)C(=O)N(Cc2ccccc2)C12CCN(C(=O)C1CCC1)CC2 |
| InChI | InChI=1S/C23H30N2O5/c1-2-30-22(29)18-19(26)21(28)25(15-16-7-4-3-5-8-16)23(18)11-13-24(14-12-23)20(27)17-9-6-10-17/h3-5,7-8,17-19,26H,2,6,9-15H2,1H3/t18-,19-/m1/s1 |
| InChIKey | JFZFIBLSDOYOQQ-RTBURBONSA-N |
| XLogP | 1.73 |
| TPSA | 87.15 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 414.50 |
| LogP ≤ 5 | 1.73 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134786325 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.